In his novel, The Pickwick Papers, published 1836, English writer Charles Dickens writes about Joe, a fat, red-faced boy who suffered from severe daytime sleepiness.
“Sleep!” said the old gentleman, ‘he’s always asleep. Goes on errands fast asleep, and snores as he waits at table.”
Later, the term Pickwickian syndrome was used to describe a condition in which severe obesity lead to a failure of the person to breathe efficiently, resulting in low levels of oxygen in the blood and high levels of carbon dioxide.
Everything suggests that Joe, the young lad, suffered from obstructive sleep apnea (OSA), a condition characterized by a repetitive obstruction of the upper airway during sleep.
Obesity is the biggest risk factor for OSA. Obese individuals often have enlargement of soft tissue within and surrounding the airways. They may be able to compensate for the upper airway narrowing during wakefulness, but this protective effect is lost during sleep when relaxation of the muscle occurs.
How Common Is OSA?
Recent estimates suggest that the prevalence of OSA has increased substantially over the last two decades.
The estimated prevalence among US adults is approximately 20 to 30 percent in males and 10 to 15 percent in females when OSA is defined broadly. If more stringent criteria are used, approximately 13 percent of men and 6 percent of women have moderate or severe OSA (1).
The increased prevalence of obesity is believed to be responsible for the increasing number of people with OSA. It is estimated that 50 to 60 percent of people who are obese or have metabolic syndrome also have OSA (2, href=”http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0012065″ target=”_blank”>3).
OSA is approximately two to three times more common in males than females, although the gap narrows at the age of menopause in women (4).
Relatively few people with symptomatic OSA receive a diagnosis of OSA and even fewer receive treatment (5).
Symptoms of OSA
Persons with OSA commonly experience loud snoring, choking or gasping during sleep, low oxygen saturation in blood, and disruption of sleep.
Disrupted sleep can result in excessive daytime sleepiness, somnolence, and impaired concentration during the day.
Snoring is a common feature of OSA. However, although 80 to 90 percent of people with OSA report snoring, many people who snore don’t have OSA.
It is often helpful to ask the patient’s bed partner about the magnitude of snoring because he/she may provide greater insight than the patient into the amount of the snoring, as well as events such as gasping or periods of silence followed by loud snoring.
Daytime sleepiness is a key feature of OSA.
When evaluating symptoms, it is important to acknowledge the difference between daytime sleepiness and fatigue.
Sleepiness is the inability to remain fully awake or alert during the day while fatigue is a subjective lack of physical or mental energy interfering with daily activities.
Sometimes people with sleepiness use terms like fatigue, tiredness, and low energy to describe their symptoms.
However, careful questioning usually reveals a pattern of feeling sleepy or falling asleep in boring or passive situations. The patient may easily fall asleep while reading and watching television.
High Blood Pressure
There is a strong association between OSA and high blood pressure (8).
The relationship between high blood pressure and OSA is believed to be due to many factors. Sympathetic overactivity, oxidative stress, and endothelial dysfunction may all play a role.
Type 2 Diabetes
Nonalcoholic Fatty Liver Disease (NAFLD)
Although nonalcoholic fatty liver disease (NAFLD) is associated with obesity, the underlying mechanisms are not fully understood.
There is evidence suggesting that OSA may increase the risk of NAFLD in people with obesity (15). It has been suggested that intermittent fall in blood oxygen levels in OSA may damage liver cells and exacerbate NAFLD in people with obesity (16).
Atrial fibrillation is the most commonly encountered arrhythmia in clinical practice and a major cause of morbidity and mortality. Over 2 million adults in the US have atrial fibrillation (17).
A strong association between OSA and atrial fibrillation has been consistently observed in both epidemiological and clinical cohorts (18).
Obesity and the severity of nighttime hypoxia, are independent risk factors for atrial fibrillation (19).
Treatment of OSA with CPAP appears to reduce the recurrence of atrial fibrillation (20).
Diagnosing Obstructive Sleep Apnea
The challenge is to select the patients who are most likely to have OSA for further testing, since expensive and time-consuming testing has traditionally been required to identify OSA.
Questionnaires are often used to screen individuals for further diagnostic evaluation. The most commonly used is test the Epworth Sleepiness Scale (ESS) (21).
Polysomnography is considered the reference standard for diagnosing OSA. However, it requires specialized resources, is expensive and has to be performed in a sleep laboratory setting.
Out-of-center sleep testing (OCST) or portable monitoring is an unattended monitoring of cardiorespiratory parameters during sleep. There is a wide variety of devices available many of whom have been validated against standard polysomnography.
The diagnosis of OSA is based on the presence or absence of related symptoms, as well as the frequency of respiratory events during sleep as measured by polysomnography or OCST.
The Disease Spectrum
The apnea-hypopnea index (AHI) represents the number of apnea (complete cessation of breathing) and hypopnea (partial obstruction) events per hour of sleep. An AHI of less than 5 is considered normal.
Patients with OSA are traditionally classified as having mild, moderate or severe disease on the basis of symptoms and the AHI.
Mild OSA: An AHI between 5 and 15 respiratory events per hour of sleep. This is usually associated with mild symptoms.
Moderate OSA: An AHI between 15 and 30 respiratory events per hour of sleep. Such patients usually experience daytime sleepiness, and they may have an increased incidence of motor vehicle violations or accidents.
Severe OSA: An AHI greater than 30 respiratory events per hour of sleep and/or an oxyhemoglobin saturation below 90 percent for more than 20 percent of the total sleep time. Such patients usually have daytime sleepiness that interferes with normal daily activities. They tend to fall asleep often during the day and are at risk for accidental injury. Patients with severe OSA are at increased risk for all-cause mortality, high blood pressure, coronary artery disease, and arrhythmias.
Treatment of OSA
Untreated OSA has many potential consequences and is associated with adverse clinical outcomes including excessive daytime sleepiness, cognitive impairment, risk of diabetes, high blood pressure, and atrial fibrillation.
OSA should be approached as a chronic disorder that requires long-term, multidisciplinary management. Therefore, apart from treating OSA itself, lifestyle modification and treatment of other risk factors is of key importance.
The goals of OSA therapy are to resolve signs and symptoms of OSA, improve sleep quality, normalize the AHI, and improve oxygen saturation of blood during sleep.
Sleep position may play a role. Some patients have OSA that develops or worsens during sleep in the supine position. Such patients usually have less severe OSA and sleeping in a non-supine position may improve their symptoms.
Weight loss and exercise should be recommended to all patients with OSA, who are overweight or obese. Weight loss has been shown to improve overall health and metabolic parameters, decrease the AHI, reduce blood pressure, improve quality of life, and decrease daytime sleepiness (22,23,24).
It is reasonable to recommend all patients with untreated OSA to avoid alcohol as it can exacerbate OSA, worsen sleepiness, and promote weight gain. Acute alcohol consumption usually worsens the duration and frequency of sleep apnea (25).
Positive Airway Pressure Therapy
Positive airway pressure therapy is the mainstay of treatment for adults with OSA.
The method uses mild air pressure to keep the airways open. The patient uses a a mask that fits over the nose or the nose and mouth. Straps keep the mask in place. A tube connects the mask to a machine that blows air into the tube.
The mechanism of involves maintenance of a positive pharyngeal transmural pressure so that the pressure within the airways exceeds the surrounding pressure. As a result, respiratory events due to collapse of the upper airways are prevented.
There is very strong evidence from randomized trials that positive airway pressure therapy reduces the frequency of respiratory events during sleep, decreases daytime sleepiness, lowers blood pressure, and improves quality of life (26,27,28, 29).
There are an increasing number of oral appliances that are designed to either protrude the chin bone (mandible) forward or hold the tongue in a more forward position. This may help maintain the potency of the upper airways.
Oral appliances may be offered to patients with mild to moderate OSA who decline or fail to adhere to positive airway pressure therapy and who have a preference for such treatment.
Upper Airway Surgery
There is no consensus regarding the role of surgery in patients with OSA, nor have optimal screening or imaging procedures been established that accurately predict which patients are most likely to benefit from surgery.
Surgical treatment appears to be most effective in patients who have OSA due to a severe, surgically correctable, obstructing lesion of the upper airway.
Surgical therapy is often considered when positive airway pressure or an oral appliance is declined or ineffective.
A variety of surgical procedures is available for the treatment of OSA in patients without a discrete anatomic lesion obstructing the upper airway. However, the efficacy of these procedures has not been extensively studied.
The Take Home Message
Due to the rapidly increasing prevalence of obesity, OSA is becoming more common.
Apart from adversely affecting the quality of life, OSA is strongly associated with the risk of diabetes, high blood pressure, liver disorders and cardiovascular disease.
Many people with OSA don’t receive treatment because they are not properly diagnosed.
Treatment of OSA usually improves quality of life and reduces the risk of associated disorders.